Gene expression analysis in Interleukin-12-induced suppression of mouse mammary carcinoma
Open Access
- 15 March 2004
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 110 (4), 570-578
- https://doi.org/10.1002/ijc.20145
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Administration of Recombinant Rhesus Interleukin-12 during Acute Simian Immunodeficiency Virus (SIV) Infection Leads to Decreased Viral Loads Associated with Prolonged Survival in SIVmac251-Infected Rhesus MacaquesJournal of Virology, 2002
- Interleukin 12 Gene Therapy of Cancer by Peritumoral Injection of Transduced Autologous Fibroblasts: Outcome of a Phase I StudyHuman Gene Therapy, 2001
- Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanismCancer Gene Therapy, 2000
- The secreted glycoprotein CREG enhances differentiation of NTERA-2 human embryonal carcinoma cellsOncogene, 2000
- Metastasis-association of the rat ortholog of the human epithelial glycoprotein antigen EGP314Oncogene, 1999
- Tumor Cell Responses to IFNγ Affect Tumorigenicity and Response to IL-12 Therapy and AntiangiogenesisImmunity, 1998
- Interleukin 12: Newest Member of the Antiangiogenesis ClubJNCI Journal of the National Cancer Institute, 1995
- Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma CellsScience, 1993
- MHC antigens and cancer: implications for T-cell surveillanceCurrent Opinion in Immunology, 1992
- The matrix‐degrading metalloproteinasesBioEssays, 1992